Skip to main content
. 2022 Apr 19;15:28. doi: 10.1186/s13047-022-00533-8

Table 1.

Quality assessments of IWGDF guideline to adopt or adapt; using a customised AGREE II instrument*

Item No. Item description Assessor 1 Assessor 2 Assessor 3 Assessor 4 Total score Total score % Quality category^
Scope and purpose
 1 The overall objective(s) of the guideline is (are) specifically described 6 7 6 6 25 89% High
 2 The health question(s) covered by the guideline is (are) specifically described 6 6 7 7 26 93% High
 3 The population (patients, public, etc.) to whom the guideline is meant to apply is specifically described. 6 6 7 7 26 93% High
Domain Score (sum of 3 items) 18 19 20 20 77 92% High
Stakeholder involvement
 4 The guideline development group includes individuals from all relevant professional groups. 5 6 5 4 20 71% High
 5 The views and preferences of the target population (patients, public, etc.) have been sought. 3 2 1 2 8 29% Low
 6 The target users of the guideline are clearly defined. 5 5 7 6 23 82% High
Domain Score (sum of 3 applicable items) 13 13 13 12 51 61% Moderate
Rigour of development
 7 Systematic methods were used to search for evidence. 7 7 7 7 28 100% High
 8 The criteria for selecting the evidence are clearly described. 7 7 7 7 28 100% High
 9 The strengths and limitations of the body of evidence are clearly described. 6 7 7 6 26 93% High
 10 The methods for formulating the recommendations are clearly described. 6 6 6 6 24 86% High
 11 The health benefits, side effects, and risks have been considered in formulating the recommendations. 5 7 7 6 25 89% High
 12 There is an explicit link between the recommendations and the supporting evidence. 5 6 7 6 24 86% High
 13 The guideline has been externally reviewed by experts prior to its publication. 5 5 4 5 19 68% Moderate
 14 A procedure for updating the guideline is provided. 5 6 5 6 22 79% High
Domain Score (sum of 8 items) 46 51 50 49 196 88% High
Clarity of presentation
 15 The recommendations are specific and unambiguous. 6 6 7 7 26 93% High
 16 The different options for management of the condition or health issue are clearly presented. 6 6 7 6 25 89% High
 17 Key recommendations are easily identifiable. 7 7 7 7 28 100% High
Domain Score (sum of 3 items) 19 19 21 20 79 94% High
Applicability
 18 The guideline describes facilitators and barriers to its application. 5 5 4 5 19 68% Moderate
 19 The guideline provides advice and/or tools on how the recommendations can be put into practice. 5 7 3 4 19 68% Moderate
 20 The potential resource implications of applying the recommendations have been considered. 5 5 2 4 16 57% Moderate
 21 The guideline presents monitoring and/or auditing criteria. 4 6 1 5 16 57% Moderate
Domain Score (sum of 4 items) 19 23 10 18 70 63% Moderate
Editorial independence
 22 The views of the funding body have not influenced the content of the guideline. 7 7 7 7 28 100% High
 23 Competing interests of guideline development group members have been recorded and addressed. 6 7 7 6 26 93% High
Domain Score (sum of 2 items) 13 14 14 13 54 96% High
Overall guideline assessment
Rate the overall quality of this guideline 6 6 6 6 24 86% High
I would recommend this guideline for use. Yes Yes,with modifications Yes Yes
Total Guideline Score (sum of all 23 individual items) 128 139 128 132 527 82% High
Total Guideline Score % 80% 86% 80% 82%
Total Guideline Quality Category High High High High

*Each item is scored using a 7-point Likert-scale: 1 = lowest possible score, 7 = highest possible score

^Quality category definitions: High > 70%, Moderate 50–69%, and Low quality < 50% for total score %